| 1 | [SID22400883] | Active | Potency | 0.2818 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 0.2818 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 2 | [SID22400883] | Active | Potency | 1 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 3 | [SID22400883] | Active | Potency | 1.2589 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 4 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID22400883] | Active | Potency | 1.2995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID22400883] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 11 | [SID22400883] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 12 | [SID22400883] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 13 | [SID22400883] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 14 | [SID22400883] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 15 | [SID22400883] | Active | Potency | 2.5119 | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 16 | [SID22400883] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 17 | [SID22400883] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 18 | [SID22400883] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 19 | [SID22400883] | Active | IC50 | 3.73 | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) [AID504729, Type: confirmatory] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 3.73 [uM] | | BioAssay | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 504729 | | BioAssay type | confirmatory | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 20 | [SID22400883] | Active | IC50 | 4.375 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) [AID504317, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 4.375 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) | | AID | 504317 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 21 | [SID22400883] | Active | IC50 | 5.718 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) [AID504319, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 5.718 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) | | AID | 504319 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 22 | [SID22400883] | Active | EC50 | 6.25689 | High throughput discovery of novel modulators of ROMK K+ channel activity: Dose-Response Assay [AID2753, Type: confirmatory] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | EC50 | 6.25689 [uM] | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Dose-Response Assay | | AID | 2753 | | BioAssay type | confirmatory | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 23 | [SID22400883] | Active | Potency | 6.3096 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 24 | [SID22400883] | Active | IC50 | 6.85 | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) in the hexokinase 1 selectivity assay [AID504763, Type: confirmatory] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 6.85 [uM] | | BioAssay | Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) in the hexokinase 1 selectivity assay | | AID | 504763 | | BioAssay type | confirmatory | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 25 | [SID22400883] | Active | Potency | 7.0795 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 26 | [SID22400883] | Active | Potency | 7.0795 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 27 | [SID22400883] | Active | Potency | 7.3078 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 28 | [SID22400883] | Active | Potency | 7.9433 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 29 | [SID22400883] | Active | IC50 | 8.15 | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID504719, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 8.15 [uM] | | BioAssay | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 504719 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 30 | [SID22400883] | Active | EC50 | 9.95 | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID489024, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | EC50 | 9.95 [uM] | | BioAssay | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 489024 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID22400883] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 32 | [SID22400883] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 33 | [SID22400883] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 34 | [SID22400883] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 35 | [SID22400883] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 36 | [SID22400883] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 37 | [SID22400883] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 38 | [SID22400883] | Active | IC50 | 16.7 | Dose Response confirmation of small molecule antagonists of the CCR6 receptor: a luminescent beta-arrestin assay [AID504728, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 16.7 [uM] | | BioAssay | Dose Response confirmation of small molecule antagonists of the CCR6 receptor: a luminescent beta-arrestin assay | | AID | 504728 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 39 | [SID22400883] | Active | IC50 | 16.7 | Dose Response confirmation of small molecule antagonists of the CCR6 receptor: a luminescent beta-arrestin assay [AID504728, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | IC50 | 16.7 [uM] | | BioAssay | Dose Response confirmation of small molecule antagonists of the CCR6 receptor: a luminescent beta-arrestin assay | | AID | 504728 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 40 | [SID22400883] | Active | Potency | 17.7407 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 17.7407 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 41 | [SID22400883] | Active | Potency | 18.2117 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 18.2117 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 42 | [SID22400883] | Active | Potency | 18.2117 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 18.2117 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 43 | [SID22400883] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 44 | [SID22400883] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 45 | [SID22400883] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 46 | [SID22400883] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 47 | [SID22400883] | Active | Potency | 39.8107 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 48 | [SID22400883] | Active | EC50 | 45.855 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of POS-1 Binding to mex-3-RNA [AID1964, Type: confirmatory] | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | EC50 | 45.855 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of POS-1 Binding to mex-3-RNA | | AID | 1964 | | BioAssay type | confirmatory | | Target | POsterior Segregation family member (pos-1) [Caenorhabditis elegans] [gi:17562800] | | PubMed | | | Data Table |  |
|
| 49 | [SID22400883] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 50 | [SID22400883] | Active | | | Counter screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID2105, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22400883 | | CID | 998883 | | Outcome | Active | | BioAssay | Counter screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 2105 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|